WIPO trademark

Stockholm3 PSA Plus

MixedWIPOClass 5Class 9Class 10Class 42+1

"Stockholm3 PSA Plus" is a trademark owned by A3P Biomedical AB (publ), filed at the WIPO on April 28, 2026. It is on file and covers classes 5, 9, 10, 42 and 44.

Stockholm3 PSA Plus
Trademark as filed with the WIPO
Status
Mixed
Filed
April 28, 2026
Registered
Not yet
Expires
April 28, 2036
Application no.
Not recorded
Registration no.
1927939
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
5 classes
Ownership

Who owns Stockholm3 PSA Plus

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services Stockholm3 PSA Plus is filed for, grouped by Nice class.

  • Diagnostic test reagents for medical purposes for prostate cancer testing; pharmaceutical preparations for treatment of cancer; reagents for use in diagnostic tests for medical purposes; diagnostic test materials for medical purposes; diagnostic preparations for medical purposes; diagnostic agents for medical use.

  • Downloadable software for calculating the risk of prostate cancer; downloadable computer programs for calculating the risk of prostate cancer; downloadable computer software for prostate cancer testing; downloadable application software for calculating the risk of prostate cancer; scientific research and laboratory apparatus for measuring, quantification and analysis of proteins and genetic material; medical training simulators for educational purposes in the field of prostate cancer; scientific research and laboratory instruments for detecting proteins and genetic material for medical research and training purposes; computer peripherals devices.

  • Medical instruments, namely, protein and genetic measuring instruments for medical diagnostic purposes; medical apparatus and instruments for the diagnosis, examination, monitoring and treatment of prostate cancer; medical testing apparatus and instruments for detecting and diagnosing prostate cancer; testing probes for medical diagnostic purposes; medical diagnostic tools for calculating prostate cancer risk.

  • IT integration services; computer software development, programming and implementation for others; website hosting services; software as a service (SaaS) featuring computer software for calculating prostate cancer risk scores; rental of computer software for use in calculating cancer risk; providing temporary use of online non-downloadable computer software for calculating prostate cancer risk scores; application service provider featuring computer software for calculating prostate cancer risk scores; scientific research and analysis in the field of prostate cancer; medical and pharmacological research services in the field of prostate cancer; conducting clinical trials for others in the field of prostate cancer; scientific and medical research in the field of oncology and urology; providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website.

  • Human healthcare services, namely, disease management programs; medical services in the field of oncology and urology; medical diagnostic services in the field of oncology and urology; medical diagnostic testing services for prostate cancer; prostate cancer screening services; medical analysis services for the diagnosis and treatment of cancer and related diseases; providing online information services relating to medical and diagnostic tests, namely information regarding prostate cancer tests for diagnosis and treatment purposes; phlebotomy services; medical blood testing services; blood sampling and analysis for diagnostic or treatment purposes; providing medical information relating to prostate cancer test results; providing medical information relating to medical diagnostic test results; medical analysis services for diagnostic provided by medical laboratories; medical laboratory analysis services for the analysis of samples and blood samples taken from patients for diagnostic purposes; rental of medical equipment for use in human healthcare; medical consultancy services in the field of oncology and urology; providing medical information in the field of oncology and urology.

FAQ

About Stockholm3 PSA Plus

Who owns the trademark "Stockholm3 PSA Plus"?

The WIPO trademark "Stockholm3 PSA Plus" is owned by A3P Biomedical AB (publ).

What is the status of "Stockholm3 PSA Plus"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Stockholm3 PSA Plus and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_42866f8a-330c-48be-b250-81f4609cbc4b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_42866f8a-330c-48be-b250-81f4609cbc4b",
  "object": "trademark",
  "mark_text": "Stockholm3 PSA Plus",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2026-04-28",
  "nice_classes": [
    5,
    9,
    10,
    42,
    44
  ],
  "owners": [
    {
      "name": "A3P Biomedical AB (publ)",
      "entity_id": "ent_019f8f4b-4a6d-76c9-920c-1f663c7da617"
    }
  ]
}